Polygenic burden has broader impact on health, cognition, and socioeconomic outcomes than most rare and high-risk copy number variants.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
09 2021
Historique:
received: 19 03 2020
accepted: 11 01 2021
revised: 18 12 2020
pubmed: 3 2 2021
medline: 1 2 2022
entrez: 2 2 2021
Statut: ppublish

Résumé

Copy number variants (CNVs) are associated with syndromic and severe neurological and psychiatric disorders (SNPDs), such as intellectual disability, epilepsy, schizophrenia, and bipolar disorder. Although considered high-impact, CNVs are also observed in the general population. This presents a diagnostic challenge in evaluating their clinical significance. To estimate the phenotypic differences between CNV carriers and non-carriers regarding general health and well-being, we compared the impact of SNPD-associated CNVs on health, cognition, and socioeconomic phenotypes to the impact of three genome-wide polygenic risk score (PRS) in two Finnish cohorts (FINRISK, n = 23,053 and NFBC1966, n = 4895). The focus was on CNV carriers and PRS extremes who do not have an SNPD diagnosis. We identified high-risk CNVs (DECIPHER CNVs, risk gene deletions, or large [>1 Mb] CNVs) in 744 study participants (2.66%), 36 (4.8%) of whom had a diagnosed SNPD. In the remaining 708 unaffected carriers, we observed lower educational attainment (EA; OR = 0.77 [95% CI 0.66-0.89]) and lower household income (OR = 0.77 [0.66-0.89]). Income-associated CNVs also lowered household income (OR = 0.50 [0.38-0.66]), and CNVs with medical consequences lowered subjective health (OR = 0.48 [0.32-0.72]). The impact of PRSs was broader. At the lowest extreme of PRS for EA, we observed lower EA (OR = 0.31 [0.26-0.37]), lower-income (OR = 0.66 [0.57-0.77]), lower subjective health (OR = 0.72 [0.61-0.83]), and increased mortality (Cox's HR = 1.55 [1.21-1.98]). PRS for intelligence had a similar impact, whereas PRS for schizophrenia did not affect these traits. We conclude that the majority of working-age individuals carrying high-risk CNVs without SNPD diagnosis have a modest impact on morbidity and mortality, as well as the limited impact on income and educational attainment, compared to individuals at the extreme end of common genetic variation. Our findings highlight that the contribution of traditional high-risk variants such as CNVs should be analyzed in a broader genetic context, rather than evaluated in isolation.

Identifiants

pubmed: 33526825
doi: 10.1038/s41380-021-01026-z
pii: 10.1038/s41380-021-01026-z
pmc: PMC8589645
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4884-4895

Subventions

Organisme : NIGMS NIH HHS
ID : R25 GM086262
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH105666
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Grayton HM, Fernandes C, Rujescu D, Collier DA. Copy number variations in neurodevelopmental disorders. Prog Neurobiol. 2012;99:81–91.
doi: 10.1016/j.pneurobio.2012.07.005
Kirov G. CNVs in neuropsychiatric disorders. Hum Mol Genet. 2015;24:R45–49.
doi: 10.1093/hmg/ddv253
Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505:361–6.
doi: 10.1038/nature12818
Sullivan PF, Daly MJ, O’Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13:537–51.
doi: 10.1038/nrg3240
Thapar A, Cooper M. Copy number variation: what is it and what has it told us about child psychiatric disorders? J Am Acad Child Adolesc Psychiatry. 2013;52:772–4.
doi: 10.1016/j.jaac.2013.05.013
Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43:838–46.
doi: 10.1038/ng.909
Coe BP, Witherspoon K, Rosenfeld JA, van Bon BWM, Vulto-van Silfhout AT, Bosco P, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet. 2014;46:1063–71.
doi: 10.1038/ng.3092
Kirov G, Rees E, Walters JTR, Escott-Price V, Georgieva L, Richards AL, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75:378–85.
doi: 10.1016/j.biopsych.2013.07.022
Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med. 2012;367:1321–31.
Vassos E, Collier DA, Holden S, Patch C, Rujescu D, St Clair D, et al. Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet. 2010;19:3477–81.
doi: 10.1093/hmg/ddq259
Kurki MI, Saarentaus E, Pietiläinen O, Gormley P, Lal D, Kerminen S, et al. Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern Finland. Nat Commun. 2019;10:410.
doi: 10.1038/s41467-018-08262-y
Pietiläinen OP, Rehnström K, Jakkula E, Service SK, Congdon E, Tilgmann C, et al. Phenotype mining in CNV carriers from a population cohort. Hum Mol Genet. 2011;20:2686–95.
doi: 10.1093/hmg/ddr162
Männik K, Mägi R, Macé A, et al. Copy number variations and cognitive phenotypes in unselected populations. JAMA. 2015;313:2044–54.
doi: 10.1001/jama.2015.4845
Kendall KM, Rees E, Escott-Price V, Einon M, Thomas R, Hewitt J, et al. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK biobank subjects. Biol Psychiatry. 2017;82:103–10.
doi: 10.1016/j.biopsych.2016.08.014
Kendall KM, Bracher-Smith M, Fitzpatrick H, Lynham A, Rees E, Escott-Price V, et al. Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. Br J Psychiatry. 2019;214:297–304.
Crawford K, Bracher-Smith M, Owen D, Kendall KM, Rees E, Pardiñas AF, et al. Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank. J Med Genet. 2019;56:131.
doi: 10.1136/jmedgenet-2018-105477
Robinson EB, St Pourcain B, Anttila V, Kosmicki JA, Bulik-Sullivan B, Grove J, et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat Genet. 2016;48:552.
doi: 10.1038/ng.3529
Macé A, Tuke MA, Deelen P, Kristiansson K, Mattsson H, Nõukas M, et al. CNV-association meta-analysis in 191,161 European adults reveals new loci associated with anthropometric traits. Nat Commun. 2017;8:744–744.
doi: 10.1038/s41467-017-00556-x
Kurki MI, Saarentaus E, Pietilainen O, Gormley P, Lal D, Kerminen S, et al. Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern Finland. Nat Commun. 2019;10:410.
doi: 10.1038/s41467-018-08262-y
Niemi MEK, Martin HC, Rice DL, Gallone G, Gordon S, Kelemen M, et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature. 2018;562:268–71.
doi: 10.1038/s41586-018-0566-4
Power RA, Steinberg S, Bjornsdottir G, Rietveld CA, Abdellaoui A, Nivard MM, et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci. 2015;18:953–5.
doi: 10.1038/nn.4040
Laursen TM, Trabjerg BB, Mors O, Borglum AD, Hougaard DM, Mattheisen M, et al. Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior—a Danish population-based study. Schizophr Res. 2017;184:122–7.
doi: 10.1016/j.schres.2016.12.001
Sørensen HJ, Debost J-C, Agerbo E, Benros ME, McGrath JJ, Mortensen PB, et al. Polygenic risk scores, school achievement, and risk for schizophrenia: a Danish population-based study. Biol Psychiatry. 2018;84:684–91.
doi: 10.1016/j.biopsych.2018.04.012
Okbay A, Beauchamp JP, Fontana MA, Lee JJ, Pers TH, Rietveld CA, et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016;533:539–42.
doi: 10.1038/nature17671
Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
doi: 10.1038/nature13595
Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–9.
doi: 10.1038/s41588-018-0152-6
Borodulin K, Vartiainen E, Peltonen M, Jousilahti P, Juolevi A, Laatikainen T, et al. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health. 2015;25:539–46.
doi: 10.1093/eurpub/cku174
Rantakallio P. The longitudinal study of the Northern Finland birth cohort of 1966. Paediatr Perinat Epidemiol. 1988;2:59–88.
doi: 10.1111/j.1365-3016.1988.tb00180.x
University of Oulu: Northern Finland Birth Cohort 1966. University of Oulu, 1966. http://urn.fi/urn:nbn:fi:att:bc1e5408-980e-4a62-b899-43bec3755243 .
Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665–74.
doi: 10.1101/gr.6861907
Marcelo Bertalan h, idaElken. iPsychCNV v1.0 (Version v1.0). Zenodo 2016.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources. Am J Hum Genet. 2009;84:524–33.
doi: 10.1016/j.ajhg.2009.03.010
Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelenberg M, et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 2015;385:1305–14.
doi: 10.1016/S0140-6736(14)61705-0
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285.
doi: 10.1038/nature19057
Vilhjalmsson BJ, Yang J, Finucane HK, Gusev A, Lindstrom S, Ripke S, et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet. 2015;97:576–92.
doi: 10.1016/j.ajhg.2015.09.001
Shaun Purcell CC PLINK version 2.0. vol. PLINK v2.00a2LM 64-bit Intel (9 Oct 2019).
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7.
doi: 10.1186/s13742-015-0047-8
Ganna A, Satterstrom FK, Zekavat SM, Das I, Kurki MI, Churchhouse C, et al. Quantifying the impact of rare and ultra-rare coding variation across the phenotypic spectrum. Am J Hum Genet. 2018;102:1204–11.
doi: 10.1016/j.ajhg.2018.05.002
Ganna A, Genovese G, Howrigan DP, Byrnes A, Kurki MI, Zekavat SM, et al. Ultra-rare disruptive and damaging mutations influence educational attainment in the general population. Nat Neurosci. 2016;19:1563–5.
doi: 10.1038/nn.4404
Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11:3635.
doi: 10.1038/s41467-020-17374-3
Mars N, Widén E, Kerminen S, Meretoja T, Pirinen M, della Briotta Parolo P, et al. The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Nat Commun. 2020;11:6383.
Ripatti P, Rämö JT, Söderlund S, Surakka I, Matikainen N, Pirinen M, et al. The contribution of GWAS loci in familial dyslipidemias. PLoS Genet. 2016;12:e1006078.
doi: 10.1371/journal.pgen.1006078
Rämö JT, Ripatti P, Tabassum R, Söderlund S, Matikainen N, Gerl MJ, et al. Coronary artery disease risk and lipidomic profiles are similar in hyperlipidemias with family history and population-ascertained hyperlipidemias. J Am Heart Assoc. 2019;8:e012415.
doi: 10.1161/JAHA.119.012415
Harald K, Salomaa V, Jousilahti P, Koskinen S, Vartiainen E. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92. J Epidemiol Community Health. 2007;61:449–54.
doi: 10.1136/jech.2006.049908
Deary IJ, Johnson W. Intelligence and education: causal perceptions drive analytic processes and therefore conclusions. Int J Epidemiol. 2010;39:1362–9.
doi: 10.1093/ije/dyq072
Mincer JA. Schooling and earnings. Schooling, experience, and earnings. NBER; 1974. p. 41–63.
Rodríguez-Pose A, Tselios V. Education and income inequality in the regions of the European Union. J Reg Sci. 2009;49:411–37.
Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27–35.
doi: 10.1038/ng.3725
Kiander J. 1990-luvun talouskriisi. Suomen akatemian tutkimusohjelma: lLaman opetukset. Suomen 1990-luvun kriisin syyt ja seuraukset. VATT Institute for economic research; 2001.
Koikkalainen P, Savela O, Sainio M, Männistö M. Gross domestic product in decline, Finland is in recession. Statistics Finland; 2009.
Tuononen M. Education in Finland: more education for more people. Statistics Finland; 2007.

Auteurs

Elmo Christian Saarentaus (EC)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Aki Samuli Havulinna (AS)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Finnish Institute for Health and Welfare, Helsinki, Finland.

Nina Mars (N)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Ari Ahola-Olli (A)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA.

Tuomo Tapio Johannes Kiiskinen (TTJ)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Juulia Partanen (J)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Sanni Ruotsalainen (S)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Mitja Kurki (M)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA.

Lea Martta Urpa (LM)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

Lei Chen (L)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.

Markus Perola (M)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Veikko Salomaa (V)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Juha Veijola (J)

Research Unit of Clinical Neuroscience, University of Oulu & Oulu University Hospital, Oulu, Finland.

Minna Männikkö (M)

Northern Finland Birth Cohorts, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland.

Ira M Hall (IM)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.

Olli Pietiläinen (O)

Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Stem Cell and Regenerative Biology, Harvard University, Cambridge, USA.
Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Jaakko Kaprio (J)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.

Samuli Ripatti (S)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA.
Department of Public Health, University of Helsinki, Helsinki, Finland.

Mark Daly (M)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA.

Aarno Palotie (A)

Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland. aarno.palotie@fimm.fi.
Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, Cambridge, MA, USA. aarno.palotie@fimm.fi.
Analytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. aarno.palotie@fimm.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH